PAG
TWST icon

Private Advisor Group’s Twist Bioscience TWST Stock Holding History

Private Advisor Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-300
Closed -$14K – 3294
2020
Q2 		$14K Buy
+300
New +$10.8K ﹤0.01% 2768

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Private Advisor Group's TWST Position: Q3 2020 in Review

Private Advisor Group sold out of Twist Bioscience (TWST) in Q3 2020, closing a stake of 300 shares — an estimated $14K sold.

Private Advisor Group first reported a position in TWST in Q2 2020 and held it in 1 quarter. The position peaked at $14K in Q2 2020. 193 funds tracked by Wall St. Rank hold TWST as of Q3 2020.

  • Private Advisor Group reported no remaining Twist Bioscience position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 300 Twist Bioscience shares in Q3 2020, an estimated $14K.
  • Private Advisor Group first reported a position in Twist Bioscience in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Twist Bioscience position peaked at $14K in Q2 2020.
  • 193 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.